3[2]Goldschlager N, Epstein AE, Naccarelli G, et al. For the practice guidelines subcommittee, North American society of pacing and electrophysiology. Practical guideline for clinicians who treat patients with amiodarone [J]. Arch Intern Med, 2000, 160: 1741.
4Goldschlager N,Epstein AE,Nacearelli G,et al.For the practice guidelines subcommittee,North American society of pacing and electrophysiology.Practical guideline for clinicians who treat patients with amiodarone[J].Arch Intern Med,2000,160:1741
5叶任高.循环系统疾病[M].人民卫生出版社,内科学:2000,213～214
6Roden DM.Electrophysiology antiarrhythmic drugs:from mechanisms to clinical practice[].Heart.2000
7Kodama I,Kamiya M,Toyama JJ.Amiodaone:Ionic and Cellulur Mechanisma of Action of the Most Promising ClassⅢAgent[].The American Journal of Cardiology.1999
8Kowey PR,Mannchak RA,Seth SJ,et al.Intravenous Antiarrthymic Therapy in the Acute Control of In-Hospital Destabilizing Ventricular Tachycardia and Fibrillation[].The American Journal of Cardiology.1999
9Yap YG,Camm AJ.Lessons from antiarrhythmic trial involving classⅢ antiarrhythmic drugs[].The American Journal of Cardiology.1999
